Skip to content

A Study on Improving Renal Function with Shen-Yang-Yin Formula Based on Symptom-Based Selection

A Study on Improving Renal Function with Shen-Yang-Yin Formula Based on Symptom-Based Selection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001188
Enrollment
Unknown
Registered
2026-05-07
Start date
2025-07-24
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure

Interventions

Experimental Group:On the basis of routine treatment, symptomatic differentiation was adopted, with Kidney-Yin-Protecting Decoction or Kidney-Yang-Protecting Decoction administered accordingly.
Control group:Routine treatment: All enrolled patients were given a high-quality low-protein, low-phosphorus and low-fat diet. Measures were adopted to control the progressive factors of chronic kidne

Sponsors

Sinopharm Datong Coal Mine General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meeting the Western medicine diagnostic criteria for Stage 1–4 Chronic Kidney Disease (CKD). 2.Patients with well-controlled hypertension, diabetes mellitus, acidosis, electrolyte imbalance, infection, and other comorbidities. 3.Aged between 18 and 80 years old, regardless of gender. 4.Voluntarily signing the informed consent form and cooperating with the conduct of this study.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women. 2.Patients with chronic renal failure who have experienced a rapid progression of renal impairment recently. 3.Patients requiring dialysis treatment. 4.Patients complicated with severe primary diseases, gastrointestinal bleeding, or mental disorders. 5.Patients who have taken glucocorticoids or immunosuppressants within the past 3 months. 6.Patients who have had cough, fever, diarrhea, acute infection, surgery, trauma, or other conditions within the past 2 weeks. 7.Patients with known allergy to any drug involved in this study or those who are unable to tolerate such drugs.

Design outcomes

Primary

MeasureTime frame
Endogenous Creatinine Clearance Rate (Ccr);Serum Creatinine (Scr);Glomerular Filtration Rate;Blood Urea Nitrogen (BUN);Uric Acid (UA);Urinary Microalbumin (UmAlb);24-Hour Urinary Protein Quantification (24h UPQ);Diagnostic Scale for TCM Symptoms of Chronic Renal Failure;

Countries

China

Contacts

Public ContactQiaoli Yang

Sinopharm Datong Coal Mine General Hospital

983378183@qq.com+86 178 8880 8862

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026